[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate

C30H44N2O6S — CID 72709090

IUPAC[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate
SMILESC=C[C@]1(C)C[C@@H](OC(=O)CSc2c(N(C)CCNC)c(=O)c2=O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
InChIInChI=1S/C30H44N2O6S/c1-8-28(4)15-20(38-21(34)16-39-25-22(23(35)24(25)36)32(7)14-13-31-6)29(5)17(2)9-11-30(18(3)27(28)37)12-10-19(33)26(29)30/h8,17-18,20,26-27,31,37H,1,9-16H2,2-7H3/t17-,18+,20-,26+,27+,28-,29+,30+/m1/s1
InChIKeyWDNBZXXOFLGQET-AGRYBOGKSA-N
MW560.76 g/mol
LogP2.94
Rot. Bonds9

About [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate

[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate (PubChem CID 72709090) has the molecular formula C30H44N2O6S and a molecular weight of 560.76 g/mol. Its IUPAC name is [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate.

Molecular Properties

Compound Name[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate
PubChem CID72709090
Molecular FormulaC30H44N2O6S
Molecular Weight560.76 g/mol
Exact Mass560.29
IUPAC Name[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate
SMILESC=C[C@]1(C)C[C@@H](OC(=O)CSc2c(N(C)CCNC)c(=O)c2=O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
InChIInChI=1S/C30H44N2O6S/c1-8-28(4)15-20(38-21(34)16-39-25-22(23(35)24(25)36)32(7)14-13-31-6)29(5)17(2)9-11-30(18(3)27(28)37)12-10-19(33)26(29)30/h8,17-18,20,26-27,31,37H,1,9-16H2,2-7H3/t17-,18+,20-,26+,27+,28-,29+,30+/m1/s1
InChIKeyWDNBZXXOFLGQET-AGRYBOGKSA-N
XLogP2.94
TPSA113.01 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds9
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500560.76
LogP ≤ 52.94
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate?
The IUPAC name of [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate (CID 72709090) is [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate.
What is the SMILES notation for [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate?
The canonical SMILES for [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate is C=C[C@]1(C)C[C@@H](OC(=O)CSc2c(N(C)CCNC)c(=O)c2=O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O.
What is the InChIKey of [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate?
The InChIKey is WDNBZXXOFLGQET-AGRYBOGKSA-N. The full InChI is InChI=1S/C30H44N2O6S/c1-8-28(4)15-20(38-21(34)16-39-25-22(23(35)24(25)36)32(7)14-13-31-6)29(5)17(2)9-11-30(18(3)27(28)37)12-10-19(33)26(29)30/h8,17-18,20,26-27,31,37H,1,9-16H2,2-7H3/t17-,18+,20-,26+,27+,28-,29+,30+/m1/s1.
What are the key properties of [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate?
[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate has a molecular weight of 560.76 g/mol, XLogP of 2.94, 9 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-[methyl-[2-(methylamino)ethyl]amino]-3,4-dioxocyclobuten-1-yl]sulfanylacetate is sourced from PubChem (CID 72709090), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).